What is the recommended Augmentin (amoxicillin‑clavulanate) dosing for acute otitis media in children and adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Augmentin Dosing for Acute Otitis Media

For children with acute otitis media, use high-dose amoxicillin-clavulanate at 90 mg/kg/day of the amoxicillin component (with 6.4 mg/kg/day clavulanate) divided into two doses for 10 days when coverage for β-lactamase-producing organisms or penicillin-resistant S. pneumoniae is needed. 1

Pediatric Dosing

Standard Indications

  • High-dose formulation (Augmentin ES-600): 90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate, divided every 12 hours for 10 days 1, 2
  • This provides a 14:1 ratio of amoxicillin to clavulanate, maximizing amoxicillin exposure while minimizing clavulanate-related diarrhea 3

When to Use High-Dose Amoxicillin-Clavulanate

Use high-dose amoxicillin-clavulanate (rather than amoxicillin alone) as first-line therapy when: 1

  • Child received amoxicillin in the previous 30 days
  • Concurrent purulent conjunctivitis (otitis-conjunctivitis syndrome)
  • Coverage for β-lactamase-producing H. influenzae or M. catarrhalis is desired
  • Child is under 2 years with severe or bilateral AOM 4
  • History of recurrent AOM or treatment failure

Age-Specific Considerations

  • Under 6 months: Prompt antibiotic treatment always recommended 4
  • 6 months to 2 years: Prompt treatment for all AOM (unilateral or bilateral, mild or severe) 4
  • Over 2 years: Watchful waiting acceptable for mild unilateral AOM or mild bilateral AOM; prompt treatment for severe bilateral AOM 4
  • Safety established: Ages 3 months to 12 years 2

Clinical Evidence Supporting High-Dose Formulation

The FDA-approved high-dose formulation demonstrated exceptional efficacy in clinical trials: 2

  • 98.4% bacteriologic eradication of all S. pneumoniae strains
  • 85.7% eradication of penicillin-resistant S. pneumoniae (MIC = 4 mcg/mL)
  • 92.6% eradication of H. influenzae
  • 89.1% clinical success at end of therapy

Recent real-world data confirms amoxicillin (including amoxicillin-clavulanate) maintains superior outcomes with lower treatment failure rates (1.7%) compared to cefdinir (10.0%) or azithromycin (9.8%) 5.

Adult Dosing

For adults with acute bacterial sinusitis (extrapolating to AOM when indicated):

  • Standard dose: Amoxicillin 875 mg with clavulanate 125 mg twice daily for 7-10 days
  • High-dose regimens (doubling amoxicillin) showed no additional benefit over standard dosing in adults and are not recommended 6

Treatment Duration

  • 10 days is the recommended duration for children, particularly those under 2 years 1, 2
  • 5-7 days may be considered for older children to improve compliance, though 10 days remains standard 7

Safety Profile

Common adverse effects (similar between standard and high-dose formulations): 2

  • Diarrhea: 12.9% (protocol-defined)
  • Vomiting: 6.5-6.9%
  • Diaper rash: 6.0-6.1%
  • Fever: 5.5-6.1%

Critical point: The twice-daily high-dose formulation (90/6.4 mg/kg/day) produces similar or lower rates of diarrhea compared to three-times-daily standard dosing (40/10 mg/kg/day), while providing superior coverage 8, 9.

Key Clinical Pitfalls to Avoid

  1. Don't underdose: The 90 mg/kg/day amoxicillin component is essential for penicillin-resistant S. pneumoniae coverage; standard 40-45 mg/kg/day is insufficient for resistant strains 1

  2. Don't use standard amoxicillin-clavulanate ratios: The 14:1 ratio (ES-600 formulation) is specifically designed to maximize amoxicillin while minimizing clavulanate-related GI effects 3

  3. Don't substitute cephalosporins or macrolides as first-line: Amoxicillin-based therapy demonstrates superior efficacy; reserve alternatives for true penicillin allergy 1, 5

  4. Penicillin allergy considerations: Cross-reactivity between penicillins and cephalosporins is lower than historically reported (<10%); second/third-generation cephalosporins (cefdinir, cefuroxime, ceftriaxone) can be used in non-severe penicillin allergies 1

Treatment Algorithm Summary

First-line for most pediatric AOM requiring antibiotics: High-dose amoxicillin-clavulanate 90/6.4 mg/kg/day divided twice daily × 10 days when risk factors present 1, 4

Treatment failure at 48-72 hours: Switch to ceftriaxone 50 mg/kg IM/IV daily for 3 days 1

True penicillin allergy: Cefdinir 14 mg/kg/day, cefuroxime 30 mg/kg/day, or ceftriaxone 50 mg/kg/day 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.